HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suppression of frequently recurring genital herpes: acyclovir v inosine pranobex.

Abstract
The suppressive action of acyclovir and inosine pranobex was compared in a randomised double blind controlled trial in patients with frequently recurring genital herpes. Fourteen patients received acyclovir and 17 inosine pranobex. Treatment continued for 12 weeks. The time to the first recurrence was significantly longer and the frequency of recurrences significantly less in the recipients of acyclovir. No important side effects were noted. It is concluded that acyclovir is the treatment of choice to suppress often recurring genital herpes.
AuthorsA Mindel, O Carney, C Sonnex, M Freris, G Patou, P Williams
JournalGenitourinary medicine (Genitourin Med) Vol. 65 Issue 2 Pg. 103-5 (Apr 1989) ISSN: 0266-4348 [Print] England
PMID2473952 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Inosine
  • Inosine Pranobex
  • Acyclovir
Topics
  • Acyclovir (therapeutic use)
  • Adult
  • Clinical Trials as Topic
  • Double-Blind Method
  • Female
  • Herpes Genitalis (drug therapy)
  • Humans
  • Inosine (analogs & derivatives)
  • Inosine Pranobex (therapeutic use)
  • Male
  • Random Allocation
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: